Pancreatic Cancer Research

ResearcherUniversity of South ChinaActive in the last 2 years

Guodong Chen

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5136976574. Sources: ClinicalTrials.gov.

Their work

Papers
1 (first author 0, last author 1)
Trials
3
Grants
0
Labs led
0
Collaborators
2
Papers, trials and grants by year

2023: 3 trials · 2024: none · 2025: none · 2026: 1 paper

Papers 1

  1. ALKBH5/IGF2BP1-mediated m6A demethylation of TRIM37 promotes pancreatic cancer tumorigenesis and glycolysis by mediating RBMX degradation. Last author DOI 10.1007/s10565-026-10173-4↗

Trials 3

  1. A Prospective Clinical Study Using an Artery-first Intermediate Approach in Robot-assisted Pancreaticoduodenectomy Study chair NCT05660915↗
  2. A Prospective Study on the Safety and Efficacy of Robot-assisted Pancreaticoduodenectomy Study chair NCT05755594↗
  3. A Multicenter Prospective Randomized Controlled Study of RPD Versus LPD Study chair NCT05755607↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Di Wu · 1 shared paper, 2026 · strength 0.32
  2. Cheng Yan · 1 shared paper, 2026 · strength 0.32

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.